We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.6B
AUM Growth
-$813M
Cap. Flow
-$1.34B
Cap. Flow %
-10.62%
Top 10 Hldgs %
15.55%
Holding
605
New
149
Increased
96
Reduced
113
Closed
185

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$269M
2
GE icon
GE Aerospace
GE
+$170M
3
ADI icon
Analog Devices
ADI
+$142M
4
KEY icon
KeyCorp
KEY
+$122M
5
MSI icon
Motorola Solutions
MSI
+$108M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$213M
2
GGP
GGP Inc.
GGP
+$153M
3
GD icon
General Dynamics
GD
+$143M
4
ZBH icon
Zimmer Biomet
ZBH
+$119M
5
EQIX icon
Equinix
EQIX
+$104M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Industrials 16.34%
3 Healthcare 11.75%
4 Consumer Discretionary 11.52%
5 Financials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUNT
301
CALL
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
$2.93M 0.02%
300,000
– –
SNDX icon
302
Syndax Pharmaceuticals
SNDX
$1.76B
$2.9M 0.02%
330,910
– –
KIDS icon
303
OrthoPediatrics
KIDS
$586M
$2.85M 0.02%
+148,600
New +$2.84M
OPTN
304
DELISTED
OptiNose
OPTN
$2.83M 0.02%
+10,000
New +$2.81M
FBP icon
305
First Bancorp
FBP
$4.44B
$2.81M 0.02%
+550,000
New +$2.74M
CBIO
306
Crescent Biopharma
CBIO
$610M
$2.73M 0.02%
1,628
-1,962
-55% -$2.59M
TELL
307
DELISTED
Tellurian Inc.
TELL
$2.7M 0.02%
+276,970
New +$2.97M
LLL
308
DELISTED
L3 Technologies, Inc.
LLL
$2.69M 0.02%
+13,608
New +$2.59M
FSTX
309
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.69M 0.02%
50,000
– –
WCG
310
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.65M 0.02%
13,185
+6,719
+104% +$1.3M
MSCC
311
DELISTED
Microsemi Corp
MSCC
$2.64M 0.02%
51,091
-175,791
-77% -$9.24M
AUPH icon
312
Aurinia Pharmaceuticals
AUPH
$2.07B
$2.63M 0.02%
581,517
-100,000
-15% -$555K
LITE icon
313
Lumentum
LITE
$65.2B
$2.59M 0.02%
+53,025
New +$2.96M
NVRO
314
DELISTED
NEVRO CORP.
NVRO
$2.58M 0.02%
+37,400
New +$2.99M
TOVX icon
315
CALL
Theriva Biologics
TOVX
$10.3M
$2.54M 0.02%
571
-572
-50% -$3.57M
ZWS icon
316
Zurn Elkay Water Solutions
ZWS
$8.6B
$2.51M 0.02%
+199,979
New +$2.41M
ZLAB icon
317
Zai Lab
ZLAB
$2.36B
$2.47M 0.02%
116,155
+16,155
+16% +$430K
ATYR
318
aTyr Pharma
ATYR
$49.2M
$2.47M 0.02%
50,323
-3,572
-7% -$220K
LDOS icon
319
Leidos
LDOS
$17B
$2.45M 0.02%
+37,912
New +$2.38M
AZUL
320
DELISTED
Azul
AZUL
$2.38M 0.02%
+100,000
New +$2.56M
CSLT
321
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.38M 0.02%
634,885
– –
SYNC
322
DELISTED
Synacor, Inc.
SYNC
$2.35M 0.02%
1,021,263
-286,521
-22% -$712K
ESNT icon
323
Essent Group
ESNT
$6.04B
$2.31M 0.02%
+53,294
New +$2.32M
SOGO
324
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$2.31M 0.02%
+200,000
New +$2.45M
DCPH
325
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.28M 0.02%
100,415
-3,235
-3% -$63.3K
11 12
13
14 15

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q4 2017 Portfolio in Review

As of Q4 2017, Alyeska Investment Group held 605 positions worth $12.6B, down 6.1% from $13.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group withdrew a net $1.34B in Q4 2017, closing 185 positions and reducing 113 holdings. Its most notable exit was Texas Instruments, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in IBM worth $272M.

  • Alyeska Investment Group's largest Q4 2017 buy was IBM: 1,851,994 shares worth $272M.
  • Alyeska Investment Group added most to KeyCorp in Q4 2017, an estimated $122M increase.
  • Alyeska Investment Group's biggest Q4 2017 reduction was Equinix, cutting an estimated $104M.
  • Alyeska Investment Group fully exited Texas Instruments in Q4 2017, selling an estimated $213M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $12.6B portfolio in Q4 2017.
  • Alyeska Investment Group opened 149 new positions and closed 185 in Q4 2017.
  • Alyeska Investment Group's portfolio value fell 6.1% quarter-over-quarter to $12.6B.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.